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Abstract
Because leukocyte-mediated tissue damage is an important
component of the pathologic picture in ischemia/reperfusion,
we have sought mechanisms by which PMNs are directed into
hypoxic tissue. Incubation of human endothelial cells (ECs) in
hypoxia, Po2 - 14-18 Torr, led to time-dependent release of
IL-8 antigen into the conditioned medium; this was accompa-
nied by increased chemotactic activity for PMNs, blocked by
antibody to IL-8. Production of IL-8 by hypoxic ECs occurred
concomitantly with both increased levels of IL-8 mRNA, based
on polymerase chain reaction analysis, and increased IL-8 tran-
scription, based on nuclear run-on assays. Northern analysis of
mRNA from hypoxic ECs also demonstrated increased levels
of mRNA for macrophage chemotactic protein-i, another
member of the chemokine superfamily of proinflammatory cy-
tokines. IL-8 gene induction was associated with the presence
of increased binding activity in nuclear extracts from hypoxic
ECs for the NF-kB site. Studies with human umbilical vein
segments exposed to hypoxia also demonstrated increased elab-
oration of IL-8 antigen compared with normoxic controls. In
mice exposed to hypoxia (Po2 30-40 Torr), there was in-
creased pulmonary leukostasis, as evidenced by increased mye-
loperoxidase activity in tissue homogenates. In parallel, in-
creased levels of transcripts for IP-10, a murine homologue in
the chemokine family related to IL-8, were observed in hypoxic
lung tissue. Taken together, these data suggest that hypoxia
constitutes a stimulus for leukocyte chemotaxis and tissue leu-
kostasis. (J. Clin. Invest. 1994. 93:1564-1570.) Key words:
hypoxia * leukostasis * ischemia * cytokine * chemokine
Introduction
There is a large pool of resident macrophages in the lung; neu-
trophils (PMNs), as well as additional mononuclear phagocytes
are recruited in response to inflammatory stimuli ( 1-2). Lung
vasculature is also sensitive to hypoxia, as indicated by the
rapid vasoconstriction which occurs with decreased oxygen
tension in the alveoli (3). Since vascular injury and hypoxia
can involve PMNs (4-10), we have focussed on mechanisms
which selectively draw leukocytes into ischemic loci. In this
context, two important mechanisms are enhanced expression
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of leukocyte adhesion molecules on the endothelial cell (EC)'
surface, and the generation ofchemoattractant cytokines lead-
ing to egress ofPMNs from the intravascular space. Enhanced
PMN-vascular interactions have also been demonstrated in
ischemic tissues in association with increased generation of
reactive oxygen intermediates (11-14), increased expression
of platelet-activating factor ( 15-17), as well as the increased
expression of IL- 1, which occurs during hypoxemia (H) and
reoxygenation (R) ( 18-19). These observations have led us to
seek mechanisms through which PMNs would leave the intra-
vascular space in hypoxic tissues.
The studies reported here demonstrate that exposure of
ECs to hypoxia leads to early, de novo synthesis of IL-8: tran-
scription is enhanced, levels of steady state mRNA rise, and
increased amounts ofchemotactically active protein are elabo-
rated. Increased IL-8 production is also observed in human
umbilical cord segments exposed to hypoxia, compared with
normoxic controls. Further, in a mouse model of hypoxia, a
gene in the IL-8 chemokine superfamily of proinflammatory
cytokines, IP- 10 (20-22), is induced and there is increased
myeloperoxidase activity in the lung, consistent with PMN in-
filtration. One mechanism underlying hypoxia-mediated in-
duction ofIL-8 may be early activation ofa transcription factor
recognizing a nuclear factor kB (NF-kB) site. The importance
of understanding the expression of IL-8 in response to hypoxia
is emphasized by a recent study demonstrating induction of
IL-8 in mononuclear phagocytes exposed to anoxia followed
by reoxygenation (23). To further complete the profile of IL-8
expression in H / R, our studies show that ECs, the first cells of
the vessel wall which encounter PMNs, produce IL-8 during
hypoxia even before the mononuclear phagocyte response dur-
ing R resulting in IL-8 elaboration. Taken together, these data
contribute to an emerging picture of ischemia-driven mecha-
nisms underlying the inflammatory response.
Methods
Endothelial cell culture and exposure of cells and umbilical cord seg-
ments to H/R. Human umbilical vein ECs were prepared from umbili-
cal cords and grown in culture by the method ofJaffe (24) as modified
by Thornton (25). Experiments used confluent ECs (passages 1-4)
grown in Medium 199 supplemented with fetal bovine serum ( 15%;
Gemini, Calabasas, CA), human serum (5%; Gemini), endothelial
growth supplement (Sigma Immunochemicals, St. Louis, MO), hepa-
rin (90 ,g/ml; Sigma Immunochemicals) and antibiotics, as described
( 18 ). When ECs achieved confluence, experiments were performed by
placing cultures in an environmental chamber (Coy Laboratory Prod-
1. Abbreviations used in this paper: EC, endothelial cells; GAPDH,
glyceraldehyde phosphate dehydrogenase; H/R, hypoxia/reoxygena-
tion; IP-10, a murine homologue in the chemokine family related to
IL-8; MCP- 1, macrophage chemotactic protein- 1; MPO, myeloperoxi-
dase; NF-kB, nuclear factor kB.
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ucts, Inc., Ann Arbor, MI), which provided a controlled temperature
(370C) and atmosphere with the indicated amount of oxygen, carbon
dioxide (5%), and the balance made up of nitrogen. Use of this
chamber for cell culture experiments has been described previously
(26). During exposure ofECs to hypoxia (for a maximum of 16 h), the
oxygen tension in the culture medium was 14-18 Torr and there was
no change in the medium pH. Reoxygenation was performed by plac-
ing ECs in an ambient atmosphere containing carbon dioxide (5%) at
370C. Cell viability was monitored by trypan blue exclusion and deter-
mination of lactate dehydrogenase release into the medium, as mea-
sured with a kit purchased from Sigma Immunochemicals.
For certain experiments umbilical cords were obtained immedi-
ately after delivery, washed in balanced salt solution, trimmed to re-
move excess adventitial tissue, and each cord was cut into pieces such
as to expose the umbilical vein endothelial cell surface. The pieces/ves-
sel segments were immersed in Medium 199 containing fetal bovine
and human serum (1%), and were incubated in the hypoxia chamber
(as above) or in a normoxic incubator (usual atmospheric culture con-
ditions with 5% carbon dioxide) for 6 h. For each of three cords, IL-8
was determined by triplicate measurements comparing segments ex-
posed to normoxia vs those segments exposed to hypoxia. Aliquots of
culture medium were assayed for IL-8 antigen in the ELISA described
below.
Assaysfor expression ofIL-8 andNorthern analysisfor macrophage
chemotactic protein-i (MCP-1). IL-8 antigen was quantified using a
sensitive capture ELISA (27). Mouse monoclonal anti-neutrophil ac-
tivating protein- I /IL-8 IgG (Sandoz Forschungsinstitut, Vienna, Aus-
tria) was used to coat wells of microtiter plates for 16 h at 4VC. After
washing four times with phosphate-buffered saline (Gibco Laborato-
ries, Grand Island, NY) containing Tween 20 (0.05%), purified hu-
man recombinant IL-8 (Sandoz, Basel, Switzerland) at concentrations
of0.02-10 ng/ml or conditioned media from EC cultures was added to
the precoated wells for 2 h at 370C. Plates were rinsed four times with
phosphate-buffered saline containing Tween-20, as above, and goat
anti-IL-8 IgG conjugated to alkaline phosphatase was added for an
additional 2 h at 370C. Next, substrate, p-nitrophenyl phosphate was
added, and plates were further incubated to allow color development,
followed by termination ofthe reaction with NaOH (2 N). Absorbance
was read at 405 nm, and the detection limit in this assay was 3.0 pg/ml.
The experiment was repeated on five separate occasions, and the results
are expressed as fold increase in IL-8 production over normoxic con-
trols.
Assays for PMN chemotaxis were performed in modified chemo-
taxis chambers as described previously (28-29). In brief, to harvest
PMNs, blood from healthy donors was drawn into EDTA (final con-
centration, 5 mM), and diluted 1:1 with NaCl (0.9%) followed by
gradient ultracentrifugation on Ficoll Hypaque (Pharmacia Fine
Chemicals, Piscataway, NJ). Leukocyte chemotaxis was performed in
48-well chemotaxis chambers (Neuro Probe, Bethesda, MD) contain-
ing a 5-Mm nucleopore polycarbonate membrane (Nucleopore Corp.,
Pleasanton, CA). PMNs were suspended in serum-free Medium 199
(Gibco Laboratories) and 104 cells were added per well to the upper
chamber. The lower chamber contained either conditioned medium
from hypoxic ECs, purified IL-8, or medium alone. The chamber was
incubated for 30 min at 37°C in a humidified air atmosphere contain-
ing carbon dioxide (5%), and after 30 min, the membrane was washed,
fixed in methanol, and Wright stained. Nine high power fields were
counted per sample, and each experiment was done in triplicate. The
results are expressed as the mean of three experiments.
PCR analysis of IL-8 transcripts was assessed in cultured ECs ex-
posed to normoxia, hypoxia, or H/R, and total RNA was extracted
using the acid-guanidinium thiocyanate procedure (Stratagene, La
Jolla, CA). Random hexanucleotide-primed first-strand cDNA was
prepared and served as a template for PCR analysis. IL-8 primers were
those described by Carre et al. (30) and glyceraldehyde phosphate dehy-
drogenase (GAPDH) primers ( 19) were 5' CCA CCC ATG GCA AAT
TCC ATG GCA 3' (sense) and 5' TCT AGA CGG CAG GTC AGG
TCC ACC 3' (antisense). cDNA was amplified by PCR for 30 cycles,
each cycle consisting of incubations at 940C for 1 min, 50'C for 2 min,
and 720C for 2 min. Products were analyzed by 1% agarose gel electro-
phoresis and visualized by ethidium bromide staining under ultraviolet
light, transferred to nylon membranes, and Southern hybridization was
performed using 32P-labeled cDNA encoding full-length human IL-8.
In control studies, the same cDNA was amplified with human GAPDH
primers described above.
Detection of a murine homologue in the chemokine family related
to IL-8 (IP- IO) and KC mRNA was also done using PCR amplification
of cDNA generated by reverse transcription using RNA from lung tis-
sue of mice exposed to hypoxia (see below) as the sample. 5 ug of each
RNA was used as starting material for the reverse transcription reaction
in a total volume of 18 Ml, and 9 MAl of the latter reaction product was
then amplified by PCR. Primers used for IP-10 were sense (5' AAC
CCA AGT GCTGCC 3') and antisense (5' ACC ATG GCT TGA CCA
3'), and for KC were sense (5' TCG CTT CTC TGT GCA GCG CT 3')
and antisense (5' GTG GTT GAC ACT TAG TGG TCT C 3') (20-
22). Amplification was carried out for 35 cycles with an annealing
temperature of 60°C. After amplification, 20 Mil of reaction product was
separated by agarose gel (1%) electrophoresis, stained with ethidium
bromide, and blotted onto nylon membranes for Southern hybridiza-
tion. The blots were hybridized with a radiolabeled cDNA probe for
IP-1O using standard methodologies.
Northern analysis for MCP- I was performed on total cellular RNA
extracted by the acid guanidinium thiocyanate method, as above.
Equal amounts ofRNA (8 Mg) were denatured and subjected to electro-
phoresis in a 1% agarose formaldehyde gel as previously described
(30). The RNA was then blotted by capillary transfer to nylon mem-
branes. The blots were prehybridized for 6-8 h at 42°C in formamide
(50%), SDS ( 1%), SSC (5X), Denhardt's solution ( Ix; Ficoll, 0.02%;
bovine serum albumin, 0.02%; polyvinylpyrrolidone, 0.02%), dena-
tured herring testes DNA (0.25 mg/ml), and sodium phosphate buffer
(pH 6.5; 50 mM). Hybridization was carried out at 42°C for 12-18 h
with MCP-l probe obtained from American Type Culture Collection
(Rockville, MD) (I0O cpm in each case). Filters were washed (SDS,
0.01%; SSC, 0.5X) for 15 min at room temperature followed by a wash
(SDS, 0.1%; SSC, 0.5X) at 65°C. Blots were then exposed to film
(XAR-5; Eastman Kodak Co., Rochester, NY) with intensifying
screens (Cronex Lightening Plus; Du Pont Pharmaceuticals, Wilming-
ton, DE) at 70°C. Expression ofGAPDH was used as an internal con-
trol for the quantity of total mRNA. In addition, the RNA per lane was
assessed by ethidium bromide staining of the original agarose gel after
capillary transfer.
Nuclear run-on assays for IL-8, GAPDH, and fl-actin. Isolation of
nuclei and in vitro transcription were performed basically as described
(31, 32). Briefly, EC cultures exposed to normoxia or hypoxia for 3 h
were washed twice with ice-cold phosphate-buffered saline, lysed in
NP-40-containing buffer (Tris/HCI, 10 mM, pH 7.4; NaCl, 10 mM;
MgCl2, 3 mM; NP-40, 0.5%), incubated on ice for 5 min, and centri-
fuged at 500 g for 5 min. Nuclei were washed in lysis buffer, resus-
pended in storage buffer (0.2 ml; Tris/HCI, 50 mM, pH 8.3; glycerol,
40%; MgCl2, 5 mM; EDTA, 0.1 mM), and kept at -80°C before use.
For in vitro transcription, the nuclei from normoxic or hypoxic ECs
(7.2 X 106) were thawed and mixed with equal volume of reaction
buffer (Tris/HCl, 10 mM, pH 8.0; MgC12, 5 mM; KCl, 300 mM)
containing 1 mM each ofATP, CTP, and GTP, and [a-32P]UTP (200
MCi, 3,000 Ci/mmol; Amersham Corp., Arlington Heights, IL). The
reaction mixture was incubated at 30°C for 30 min, and 32P-labeled
RNA was then isolated and precipitated with ethanol. RNA was hybrid-
ized to linearized plasmid DNA (IL-8, GAPDH, and ,B-actin), and
immobilized on nitrocellulose membranes for 36 h at 65°C, as de-
scribed (31). Filters were washed in SSC (2x) at 65°C three times for
30 min each, incubated at 37°C with ribonuclease A (10 Mug/ml),
washed again, air dried, and exposed to Kodak x-ray film as above.
Nuclear extracts and electrophoretic gel mobility shift assays. Nu-
clear extracts were prepared from normoxic and hypoxic ECs, or from
endothelial cultures exposed to purified recombinant human TNF (5
nM) (generously provided by Dr. P. Lomedico, Hoffmann-La Roche
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Inc., Nutley, NJ) for 3 h by the method of Dignam and Roeder (33).
These extracts were prepared in an environment with the same am-
bient oxygen tension as that in the experiment (extracts from hypoxic
cultures were prepared under hypoxia). Complementary 30-bp oligo-
nucleotides representing a portion of the human IL-8 gene promoter
containing a putative NF-kB site (34-35) or mouse NF-kB binding site
(36-37) were used: for IL-8, these included 5' CCC CAA ATC GTG
GAA TTT CCT CTG AGA TAA 3' (NF-kBl ) and 5' GGG TTA TGT
CAG AGG AAA TTC CAC GAT TTG 3' (NF-kB2); for mouse NF-
kB these included 5' CCC CAG AGG GGA CTT TCC GAG AGG
CTC 3' (NF-kBl ) and 5' GGG GAG CCT CTC GGA AAG TCC CCT
CTG 3' (NF-kB2). Oligonucleotides were annealed and 3' end-labeled
with [a-32P]dCTP and dGTP with Klenow polymerase via standard
procedures (38). Binding reactions were performed by preincubating
7.5 Mg of nuclear extract protein in Hepes (20 mM; pH 7.9), KCl (60
mM), MgCl2 (1 mM), EDTA (0.1 M), glycerol (10%), dithiothreitol
(0.5 mM), and poly (dI-dC; 2 Mg) on ice for 10 min, followed by
addition ofthe double stranded 32P-labeled oligonucleotide ( - 0.2 ng)
and a second incubation at room temperature for 20 min. Samples
were loaded directly onto nondenaturing 6% polyacrylamide gels (29:1
acrylamide/bisacrylamide) prepared in Tris (45 mM)-boric acid (45
mM)-EDTA (0.1 M) (0.5 X TBE). Electrophoresis was performed at
room temperature for 3-4 h at a current of 15 mA. Supershift experi-
ments were performed as described above except that 1 Ml of antibody
to the NF-kB binding protein p50 or p65 were added to the binding
mixture in the absence of the labelled probe. This mixture was then
incubated on ice for 45 min before probe addition. Antisera specifically
recognizing p50 (anti-SPl 141 from the N terminus of pO5) (39) or
p65 (anti-SP1226 from the N H2 terminus of p65) (39) were gener-
ously provided by Dr. N. Rice (Frederick Cancer Research and Devel-
opment Center, Frederick, MD). The gels were then dried and exposed
to Kodak XRP film with intensifying screens. For competition studies,
unlabeled probe for Spi (40) was also used: 5' GCT CCA GGC GGG
GGC GGG GCC CGG GTT CGG 3' (Sp-1-1#) and 5' CCG AAC
CCG GGC CCC GCC CCC GCC TGG AGC 3' (Sp-1-2#). Experi-
ments with unlabeled oligonucleotides used a 100-fold molar excess
relative to the radiolabeled oligonucleotide.
Determination of leukostasis and expression ofIP-JO/KC in lungs
of hypoxic mice. Mice were subjected to hypoxia as previously de-
scribed (26) and reoxygenated using a controlled environmental
chamber. Animals were placed in the chamber and allowed free access
to food and water, the system parameters were adjusted to a final oxy-
gen concentration of 8-10% oxygen with the balance ofthe gas mixture
being made up of nitrogen. At the indicated times, mice were killed,
and lung was tissue collected for RNA extraction using the acid guani-
dinium thiocyanate method as described above. PCR and Southern
blotting were performed as described above using primers for IP-10
and KC.
Pulmonary leukostasis was assessed by determining myeloperoxi-
dase (MPO) activity using previously described methods (41-42).
Mice (hypoxic, n = 3; normoxic, n = 3) were anesthetized, lungs were
rinsed with saline to remove residual blood, and then lungs were ex-
cised from the chest cavity and homogenized in phosphate buffer (50
mM; pH 6.0) containing hexadecyl trimethyl ammonium bromide
(0.5%) on ice. The homogenate was centrifuged at 40,000 g for 10 min
at 4°C, and the supernatant decanted. The pellet was freeze thawed and
resuspended in the same buffer (hexadecyl trimethyl ammonium bro-
mide). This extraction procedure was repeated three times, the extracts
were pooled, and MPO activity assayed using the standard chromo-
genic spectrophotometric technique (20, 21 ). The test sample (0.1 ml)
was added to 2.9 ml of phosphate buffer (50 mM; pH 6.0) containing
O-dianisidine dihydrochloride (Sigma Immunochemicals) and hydro-
gen peroxide (0.0005%), and change in absorbance at 460 nm was
measured during 5 min (increase in OD was linear during this time
interval). Results shown are the means of three observations ± SEM.
Data analysis. IL-8 ELISA and chemotaxis data were evaluated
using analysis of variance, with the Tukey procedure used to discrimi-
nate significant differences between group means. When two variables
were compared, the Student's t test was used for unpaired (myeloper-
oxidase data) or paired (umbilical cord segment data) variables. Data
were considered statistically significant ifP < 0.05.
Results
Elaboration of IL-8 by ECs exposed to hypoxia. When ECs
were placed in an hypoxic atmosphere (Po2 - 14-18 Torr),
IL-8 antigen was released into the culture medium in a time-
dependent manner; increasing over time to -1 ng/ml by 16 h
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Figure 1. Hypoxia and H/R induce EC release of IL-8 antigen and
PMN chemotactic activity into conditioned medium. (A) Elaboration
of IL-8 antigen. Confluent ECs were incubated in serum-free medium
199 in an hypoxic atmosphere (medium P02 - 14-18 Torr) for the
indicated times. Aliquots of the culture supernatants were assayed for
the presence ofimmunoreactive IL-8 by ELISA. The y-axis indicates
the rise in IL-8 antigen above that detectable in the conditioned me-
dium of normoxic controls and is the mean of five separate experi-
ments. The peak value of IL-8 antigen in hypoxic cultures was - I
ng/ml and was observed at 16 h. *JP < 0.05, **)P < 0.01. (B) Induc-
tion of PMN chemotaxis. Aliquots of conditioned medium from
hypoxic EC cultures ( 16 h) were added alone (darkened bars) or in
the presence of the indicated concentration of anti-(a)-IL-8 IgG to
the lower compartment of modified chemotaxis chambers. Where in-
dicated, conditioned medium from normoxic ECs ( 16 h; open bar)
or purified IL-8 (1 ng/ml; cross-hatched bar) was added to chemo-
taxis chambers. PMNs (104/well) were placed in the upper chamber,
and the assay was continued for 30 min at 37°C in a humidified am-
bient air atmosphere, as described in the text. NI IgG, addition of
nonimmune IgG at a final concentration of 75 ug/ml. The y-axis
shows the number of PMNs that migrated across the membranes in
nine high powered fields. The mean ± SEM of triplicate determina-
tions is shown. *P < 0.05.
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elaborated for up to 4 h (data not shown). Concomitantly,
chemotactic activity for PMNs was observed in the condi-
tioned medium from hypoxic EC cultures, which could be com-
pletely blocked in the presence ofmonospecific anti-IL-8 anti-
body, whereas nonimmune IgG was without effect (Fig. 1 B).
Note that IL-8 used as a positive control stimulated PMN mi-
gration at about the concentration present in conditioned me-
dium from hypoxic ECs. The increase in IL-8 production was
observed only when the Po2 was low ( 14-18 Torr) and was not
seen at higher oxygen tensions. Release of IL-8 into the condi-
tioned medium was not a result of cell death (even at the lon-
gest times of exposure to hypoxia, 16 h in these experiments),
as cell viability was unaffected: cells remained adherent as a
confluent monolayer, excluded trypan blue, and did not re-
lease increased amounts of lactate dehydrogenase.
As a first step in extrapolating these data back to an intact
vessel, elaboration of IL-8 antigen in human umbilical cord
segments, in which pieces of umbilical vein were exposed to
hypoxia, were studied. In these experiments, the hypoxic seg-
ments demonstrated increased amounts of IL-8 antigen com-
pared with normoxic controls (Fig. 2). Although multiple cells
in the vessel wall could contribute to the observed IL-8 produc-
tion, taken together with the data in cell culture, these results
are consistent with increased elaboration of IL-8 by hypoxic
vasculature.
In parallel with increased levels of IL-8 in conditioned me-
dia from hypoxic cultured ECs, PCR analysis showed en-
hanced levels of IL-8 mRNA (Fig. 3 A). Southern blotting of
the PCR products with a cDNA for IL-8 confirmed the identity
of these amplicons (Fig. 3 B). Amplification of the same
cDNA for GAPDH demonstrated that levels of transcript for
this constitutive enzyme were unaffected by hypoxia, confirm-
ing preferential induction of IL-8 mRNA (Fig. 3 C). Nuclear
run-on assays demonstrated that hypoxia increased transcrip-
tion of IL-8, whereas transcription of the housekeeping gene
f3-actin was largely unchanged (Fig. 3 D). Since total transcrip-
tion was decreased in hypoxia by 67% (data not shown), this
suggests the specificity ofthe hypoxic stimulus for induction of
IL-8. These data are consistent with increased IL-8 synthesis in
hypoxia, resulting from enhanced transcription, translation,
and release of chemotactically active protein. In support of
upregulation of genes in the chemokine superfamily of cyto-
kines, increased transcripts ofMCP-1 were observed on North-
ern analysis of RNA from hypoxic ECs compared with nor-
moxic controls (Fig. 4). Enhanced levels of MCP-l mRNA
were evident 30-60 min after placement in hypoxia and were
increased up to 2 h, thereafter falling offto the normoxic base-
line by 4 h.
Figure 2. Elaboration of
0.8.-TIL-8 antigen by umbili-
cal vein segments ex-
It '' ~ _ posed to hypoxia. Um-
b . _ bilical cord segments
0., ,,_from patients were pre-
pared and exposed to
0.2 hypoxia for 6 h as de-
scribed in the text. Ali-
0
Normoxic Cords Hypoxic Cords quots of conditioned
medium were analyzed
using the IL-8 ELISA.
The mean + SEM of triplicate determinations is shown. *P < 0.05,
hypoxia vs normoxia.













Figure 3. Induction of IL-8 mRNA in hypoxic ECs. (A and C) PCR
analysis. ECs were placed either in normoxia (N) hypoxia ( 16 h; H)
or hypoxia ( 16 h)/reoxygenation (4 h) (HIR), RNA was harvested,
and PCR was performed as described in the text. First-strand cDNA
was prepared from total RNA (1 Mg) and served as a template for
PCR in combination with primers specific for IL-8 (A) and GAPDH
(C). Results shown are ethidium bromide-stained PCR products
obtained after 30 cycles. C shows Southern hybridization of the PCR
products obtained in A using 32P-labeled cDNA for human IL-8. The
migration ofDNA markers (PhiX 174 RF DNA-Hae III digest) is in-
dicated by the arrows. (D) Transcriptional analysis of IL-8 and ,B-
actin genes by nuclear run-on assay. 4 ug of IL-8 plasmid (top) and
fi-actin plasmid (bottom) bound to nitrocellulose were hybridized
with 32P-labeled run-on transcripts from 7.2 X 106 nuclei isolated
from cultured ECs after hypoxia (3 h) or normoxia.
Mechanisms ofhypoxia-induced IL-8 production. Reactive
oxygen intermediates, whose formation is often related to
changes in intracellular redox potential, have been shown to
induce nuclear translocation ofthe transcription factor NF-kB
(43). Since a sequence element resembling an NF-kB recogni-
tion motif is present in the human IL-8 promoter, electropho-
retic mobility shift assays were performed using a synthetic,
double-stranded DNA probe representing this portion of the
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Figure 5. Binding of EC nuclear proteins to the hu-
man IL-8 promoter sequence: electrophoretic mobil-
ity shift assay. The binding of multiple nuclear pro-
teins to the putative NF-kB site of the human IL-8
promoter and a known mouse NF-kB site was dem-
onstrated using electrophoretic mobility shift assay.
Lanes 1-6 and 13-15 contain the labeled probe rep-
resenting the human IL-8 promoter, lanes 7-12 con-
tain the mouse probe. FP, unbound free probe. Addi-
tions are indicated above each lane, and details of
methods are described in the text.
moxic ECs resulted in the appearance ofmultiple shifted bands
(compare lanes 1 and 2). Exposure of ECs to hypoxic condi-
tions for 3 h resulted in a substantial increase in the binding
capacity of one of these species (see lane 3), indicated as the
hypoxia-enhanced species. The binding of this protein(s) to
the probe is sequence specific, since an excess of the unlabeled
human IL-8 promoter probe (lane 4) or ofa probe containing a
known murine NF-kB binding site (lane 5) virtually abolished
binding to the labeled probe, whereas a similar molar excess of
an unrelated probe containing a known Sp-l binding site did
not (lane 6).
The fact that both probes which contain known or putative
NF-kB binding sites compete for binding of the hypoxia-in-
duced species strongly suggests that this protein(s) recognizes
an NF-kB site. Since NF-kB is one member of a family of
transcription factors that bind to similar recognition sequences
(36-37), we sought to determine whether the hypoxia-induced
species is authentic NF-kB (i.e., the p50/p65 heterodimer) or a
distinct species. Since TNF is a known inducer of NF-kB in
ECs (44), normoxic cultures were exposed to TNF and tested
for binding activities that could specifically recognize the
known NF-kB probe (Fig. 5, lanes 7-9). A major binding spe-
cies, designated TNF-enhanced species (lanes 7-12) is ob-
served in nuclear extracts from TNF-treated ECs. The se-
quence specificity of DNA binding by these protein(s) for a
probe comprised ofa known murine NF-kB sequence (33-34)
is demonstrated by competition with excess unlabeled murine
NF-kB probe (lane 10; the appearance of the TNF-enhanced
band is completely abolished) or unlabeled human IL-8 NF-kB
probe (lane 12; the appearance of the TNF-enhanced band is
diminished, but not completely abolished, suggesting that the
TNF-induced binding proteins interact with this probe with a
lower affinity than with the mouse NF-kB probe). In contrast,
addition of excess unlabeled Sp-l probe had no effect on the
intensity of the TNF-enhanced band. To determine that the
TNF-induced species binding to NF-kB was authentic NF-kB,
supershift experiments were performed with antisera to the p50
and p65 components of NF-kB. The results demonstrate that
the TNF enhanced species is shifted by both the anti-pSO (lane
8) and anti-p65 antisera (lane 9). In conjunction with the com-
petition data, these data are strong evidence that the species
induced/enhanced by TNF is authentic NF-kB. In contrast,
supershift experiments with the same antibodies did not result
in a shift of the hypoxia-enhanced species (lane 14, anti-p5O
IgG; lane 15, anti-p65 IgG). The different mobility of the hyp-
oxia-enhanced species relative to NF-kB in the gel mobility
shift assay suggests that although it binds to NF-kB binding
sites, it is distinct from authentic NF-kB.
Effect of hypoxia on leukostasis and induction of murine
members of the IL-8-related family of chemokines in the
mouse. Mice exposed to hypoxia demonstrated increased pul-
monary leukostasis, as measured by MPO assays (Fig. 6 A).
These results led us to examine if hypoxia was a stimulus for
induction of cytokines in the IL-8-related murine family of
chemoattractant polypeptides in vivo. A fragment correspond-
ing to the expected 475-bp PCR product from IP-10 mRNA
was observed at 4 and 8 h after exposure to hypoxia and de-
clined after 24 h (Fig. 6 B). IP-10 mRNA was not detected in
normoxic control animals. Southern blotting with IP- 10 cDNA
confirmed the identity of the amplicon (Fig. 6 C). In contrast,
no induction of gro (KC) mRNA was observed.
Discussion
Exposure ofECs to hypoxia and hypoxia/reoxygenation sets in
motion events that promote margination and migration of
PMNs into the interstitium. Previous studies have demon-
strated mechanisms through which ECs subjected to hypoxia,
as well as reoxygenation have increased capacity to bind PMNs
( 18, 45 ). EC generation of a chemotactic polypeptide in isch-
emic loci could enhance the participation of circulating PMNs
in the inflammatory response. In this report, we show that hyp-
























Figure 6. Effect of hypoxia on pulmonary leukostasis and activation
of genes in the IL-8-related family in vivo. Mice were exposed to
hypoxia (P02 30-40 Torr, n = 3) or normoxia (ambient Po2,
n = 3). (A) Lungs were harvested at 16 h and processed for MPO ac-
tivity. The y-axis shows the fold increase in MPO activity in hypoxic
mouse lung as compared with normoxic controls (mean ± SEM). *P
< 0.05. (B) Lungs were harvested at 4, 8, and 22 h of hypoxia, RNA
was extracted, and PCR was performed using primers for IP- IO. The
arrow indicates the position of the expected 475-bp PCR product.
(C) Southern hybridization of these amplicons with a radiolabeled
IP-IO cDNA.
oxia results in the production ofthe chemotactic cytokine IL-8,
providing insight into a means through which ECs facilitate
emigration of PMNs from the intravascular space, either by
releasing IL-8 or, potentially, displaying this polypeptide on the
cell surface (46-47). After their adherence to the EC, PMNs
emigrate to the extravascular tissues, where they fulfill their
role in host defense.
Although pathways underlying enhanced EC expression of
IL-8 in hypoxia remain to be clarified, the association of this
phenomenon with activation of an NF-kB-related transcrip-
tion factor may be an important mechanism driving transcrip-
tion. Consistent with the presence ofNF-kB and C/EBP bind-
ing sites in the promoter ofthe human IL-8 gene, NF-kB, along
with a C/EBP-like factor, can drive expression of IL-8 (35).
The different mobility of the hypoxia-induced NF-kB species,
compared with that observed in EC cultures exposed to TNF,
as well as the supershift experiments with anti-p50 and anti-
p65 antibodies, indicates that a species distinct from authentic
NF-kB may be involved in transcriptional activation in hyp-
oxic cultures. In view ofthe evolving recognition ofthe diverse
and complex nature of the NF-kB-related family of molecules
(36-37), it is not surprising that different stimuli might use
distinct pathways to initiate transcription of target genes.
The stimulus for activation of NF-kB site binding activity
in hypoxic ECs could result from several possible mechanisms.
For example, hypoxia-induced production of EC IL-I could
result in autocrine activation of NF-kB site binding activity.
The latter seems unlikely, as induction of IL-I mRNA and
elaboration of IL-I activity from hypoxic ECs occurs later than
activation ofNF-kB binding site activity and induction ofIL-8
( 18). In support ofthis, anti-IL- I antibodies and IL- I receptor
antagonist had no effect on hypoxia-induced IL-8 production.
Studies are in progress to delineate mechanisms which are in-
volved.
Our data in the mouse model of hypoxia, also suggest po-
tential hypoxia-induced activation of other members of the
IL-8-related family of proinflammatory polypeptides. Induc-
tion of IP- 10 is associated with inflammation, for example its
production is stimulated by T cell-derived lymphokines (IFN-
'y, IL-2, TNF) and bacterial cell wall lipopolysaccharide, al-
though the biologic activities of IP-IO have not been fully de-
fined (22). To gain further insight into possible upregulation of
the murine IL-8 gene in hypoxia, we obtained a recently cloned
cDNA which appears to be the murine counterpart of IL-8
(30% identical and 50% homologous to human IL-8) (Wein-
stein, I.B., and W. Jing, manuscript in preparation), and per-
formed Northern analysis on RNA harvested from hypoxic
mouse lung tissue. The intensity ofa band corresponding to the
IL-8 mRNA increased in hypoxia at the 1-, 2-, and 4-h time
points, compared with normoxic controls. These observations
are consistent with the leukostasis observed with hypoxia in
vivo, and the results with cultured ECs and with umbilical cord
segments demonstrating increased elaboration of IL-8 antigen
on exposure to hypoxia.
Taken together, these data indicate that hypoxia enhances
EC transcription, translation, and release ofthe IL-8 gene prod-
uct, potentially attracting PMNs to areas of regional ischemia.
The combined effects of EC production of IL-8 during hyp-
oxia, and monocyte elaboration of IL-8 during reoxygenation
(8) could lead to a synergistic mechanism through which leu-
kocytes are drawn into the interstitium. Thus, regional hyp-
oxia/hypoxemia could serve as a priming stimulus that initi-
ates a local inflammatory response after reoxygenation/reper-
fusion.
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